Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,471
Recruiting: 1,282
Ph III recruiting: 129
Growth YoY: +2.6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,643)

clinicaltrialsPublishedShowing 951–1,000 of 1,574 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04747236	Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL(PTCL)	recruiting	Phase 2	50	University of VirginiaOTHER	1	Jan 21, 2026	clinicaltrials
NCT04855695	Avo In R/R And Previously Untreated MCL	recruiting	Phase 1 / Phase 2	72	Austin I KimOTHER	1	Jan 21, 2026	clinicaltrials